Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Wideout

Rank: Mail Room [?]

Points: 140 [?]

Votes: 12 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

in response to

Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

Mazola

posted on Dec 22, 2020 02:00PM

Yes Mazola , lots of crying from the same

Seniors crowd that post fluff all day/everyday,

the ones that try everyday to convince this anonymous board how vast their knowledge of the stock market is...

And we all know you those are..lol

Don and Resverlogix will be just fine ...

GLTA

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply